Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data Repository

BACKGROUND: Randomised clinical trials (RCTs) are the gold standard for evaluating new cancer treatments. They are, however, expensive to conduct, particularly where long-term follow-up of participants is required. Tracking participants via routine datasets could provide a cost-effective alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilburn, Lucy Suzanne, Aresu, Maria, Banerji, Jane, Barrett-Lee, Peter, Ellis, Paul, Bliss, Judith Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702960/
https://www.ncbi.nlm.nih.gov/pubmed/29179731
http://dx.doi.org/10.1186/s13063-017-2308-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702960/
https://www.ncbi.nlm.nih.gov/pubmed/29179731
http://dx.doi.org/10.1186/s13063-017-2308-6

Ejemplares similares